Epoch 39: Unmasking The Top Biotech Exit Enablers

Profiling the Most Active Biotech Investors of 2024

Hello Avatar!  Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update.  For the week XBI was DOWN -4% and remains green at +10% for the year. Last week, we explored how the first half of 2024 saw fewer deals and IPOs, but larger financings, with companies staying private longer to fo…